Mitsue Kurasawa

959 total citations
44 papers, 778 citations indexed

About

Mitsue Kurasawa is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mitsue Kurasawa has authored 44 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 14 papers in Molecular Biology and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mitsue Kurasawa's work include Colorectal Cancer Treatments and Studies (8 papers), HER2/EGFR in Cancer Research (6 papers) and Cancer Treatment and Pharmacology (6 papers). Mitsue Kurasawa is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), HER2/EGFR in Cancer Research (6 papers) and Cancer Treatment and Pharmacology (6 papers). Mitsue Kurasawa collaborates with scholars based in United States, Japan and Switzerland. Mitsue Kurasawa's co-authors include Keigo Yorozu, Koh Furugaki, Kaori Fujimoto-Ouchi, Masamichi Sugimoto, Kazuo Nakamura, Kaname Yamamoto, Mieko Yanagisawa, Yoriko Yamashita‐Kashima, Kazuo Nakamura and Toshiki Iwai and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Mitsue Kurasawa

43 papers receiving 725 citations

Peers

Countries citing papers authored by Mitsue Kurasawa

Since Specialization

Citations

This map shows the geographic impact of Mitsue Kurasawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsue Kurasawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsue Kurasawa more than expected).

Fields of papers citing papers by Mitsue Kurasawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsue Kurasawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsue Kurasawa. The network helps show where Mitsue Kurasawa may publish in the future.

Co-authorship network of co-authors of Mitsue Kurasawa

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsue Kurasawa. A scholar is included among the top collaborators of Mitsue Kurasawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsue Kurasawa. Mitsue Kurasawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PD-L1 and VEGF dual blockade enhances anti-tumor effect on brain metastasis in hematogenous metastasis model 2024 ·Clinical & Experimental Metastasis ·(unknown), (unknown), Keigo Yorozu, Mitsue Kurasawa, (unknown), (unknown), Masamichi Sugimoto	3
2	Infiltration of Innate Immune Cells into Tumors By Polatuzumab Vedotin Treatment Contributes to Its Antitumor Effect in Xenograft and Syngeneic Mouse Models 2024 ·Blood ·(unknown), Natsumi Kawasaki, Keigo Yorozu, Mitsue Kurasawa, (unknown), Nicolas Sax, (unknown), Yoriko Yamashita‐Kashima, (unknown)	1
3	Intradermal AQP4 peptide immunization induces clinical features of neuromyelitis optica spectrum disorder in mice 2023 ·Journal of Neuroimmunology ·Kenichi Serizawa, Shota Miyake, (unknown), Keigo Yorozu, Mitsue Kurasawa, (unknown), Hideyuki Yasuno, Yoshihiro Matsumoto	9
4	Coadministration with bendamustine restores the antitumor activity of obinutuzumab in obinutuzumab-resistant tumors 2022 ·International Journal of Hematology ·Yoriko Yamashita‐Kashima, (unknown), (unknown), Natsumi Kawasaki, Mitsue Kurasawa, (unknown), Naoki Harada, Osamu Kondoh, Yasushi Yoshimura	1
5	Methods for preparing tissue microarray slides using xenografts with different levels of HER2 expression to standardize HER2 detection 2022 ·Pathology International ·Keigo Yorozu, Mitsue Kurasawa, (unknown), Yuka Nakamura, Kaoru Hashizume, Naoki Harada, Atsushi Ochiai	2
6	PD-L1 blockade exhibits anti-tumor effect on brain metastasis by activating CD8+ T cells in hematogenous metastasis model with lymphocyte infusion 2021 ·Clinical & Experimental Metastasis ·(unknown), (unknown), Daiko Wakita, Keigo Yorozu, Mitsue Kurasawa, Masamichi Sugimoto, Osamu Kondoh	2
7	Both T cell priming in lymph node and CXCR3-dependent migration are the key events for predicting the response of atezolizumab 2021 ·Scientific Reports ·Toshiki Iwai, Masamichi Sugimoto, Namrata S. Patil, (unknown), Miho Suzuki, Chie Kato, Keigo Yorozu, Mitsue Kurasawa, David S. Shames, Osamu Kondoh	13
8	Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model 2019 ·Clinical & Experimental Metastasis ·(unknown), Masamichi Sugimoto, Daiko Wakita, Makoto Monnai, (unknown), Ryô Nakamura, Mari Kinoshita, Keigo Yorozu, Mitsue Kurasawa, Osamu Kondoh, Kaname Yamamoto	25
9	T2∗ Relaxation Time Obtained from Magnetic Resonance Imaging of the Liver Is a Useful Parameter for Use in the Construction of a Murine Model of Iron Overload 2019 ·Contrast Media & Molecular Imaging ·(unknown), Yusuke Sasaki, (unknown), Mitsue Kurasawa, Keigo Yorozu, (unknown), Michinori Hirata	5
10	Importance of Bevacizumab Maintenance Following Combination Chemotherapy in Human Non–small Cell Lung Cancer Xenograft Models 2017 ·Anticancer Research ·Nobuyuki Ishikura, Mieko Yanagisawa, (unknown), Toshiki Iwai, Keigo Yorozu, Mitsue Kurasawa, Masamichi Sugimoto, Kaname Yamamoto	6
11	Continuous administration of bevacizumab plus capecitabine, even after acquired resistance to bevacizumab, restored anti-angiogenic and antitumor effect in a human colorectal cancer xenograft model 2016 ·Oncology Reports ·Toshiki Iwai, Masamichi Sugimoto, Suguru Harada, Keigo Yorozu, Mitsue Kurasawa, Kaname Yamamoto	14
12	Antitumor activity of alectinib, a selective ALK inhibitor, in an ALK-positive NSCLC cell line harboring G1269A mutation 2016 ·Cancer Chemotherapy and Pharmacology ·Yasushi Yoshimura, Mitsue Kurasawa, Keigo Yorozu, Óscar Puig, Walter Bordogna, Naoki Harada	20
13	Reduction of a marker of oxidative stress with enhancement of iron utilization by erythropoiesis activation following epoetin beta pegol administration in iron-loaded db/db mice 2016 ·International Journal of Hematology ·(unknown), Yusuke Sasaki, (unknown), Hideyuki Yasuno, Mitsue Kurasawa, Keigo Yorozu, Yasushi Shimonaka	9
14	Epoetin beta pegol (C.E.R.A.) promotes utilization of iron for erythropoiesis through intensive suppression of serum hepcidin levels in mice 2014 ·International Journal of Hematology ·Yusuke Sasaki, (unknown), (unknown), (unknown), Mitsue Kurasawa, Keigo Yorozu, Yasushi Shimonaka	11
15	Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes 2012 ·Oncology Reports ·Hideyuki Yasuno, Mitsue Kurasawa, Mieko Yanagisawa, Yasuko Sato, Naoki Harada, Kazushige Mori	13
16	Cholinergic and dopaminergic mechanisms involved in the recovery of circadian anticipation by aniracetam in aged rats 2002 ·Pharmacology Biochemistry and Behavior ·Yushiro Tanaka, Mitsue Kurasawa, Kazuo Nakamura	4
17	Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism 2001 ·European Journal of Pharmacology ·Kazuo Nakamura, Mitsue Kurasawa	50
18	Impulsivity and AMPA receptors: aniracetam ameliorates impulsive behavior induced by a blockade of AMPA receptors in rats 2000 ·Brain Research ·Kazuo Nakamura, Mitsue Kurasawa, Masatoshi Shirane	21
19	Apomorphine-induced hypoattention in rats and reversal of the choice performance impairment by aniracetam 1998 ·European Journal of Pharmacology ·Kazuo Nakamura, Mitsue Kurasawa, Yushiro Tanaka	25
20	Dextrorphan attenuates the behavioral consequences of ischemia and the biochemical consequences of anoxia: possible role of N-methyl-d-aspartate receptor antagonism and ATP replenishing action in its cerebroprotecting profile 1993 ·Psychopharmacology ·Norio Himori, Yushiro Tanaka, Mitsue Kurasawa, Kenichi Mishima, (unknown), Mayumi Imai, Kenichi Ueno, (unknown), Hiroshi Watanabe	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact